72
Participants
Start Date
March 31, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
August 31, 2015
Ad35-GRIN
intramuscular administration of Ad35-GRIN 5 x 10\^10 vp or saline placebo
MVA.HIVconsv
IM administration of MVA.HIVconsv 2 x 10\^8 pfu or saline placebo
pSG2.HIVconsv DNA
IM administration of pSG2.HIVconsv DNA 4 mg or saline placebo
Electroporated pSG2.HIVconsv
IM administration of electroporated pSG2.HIVconsv 4mg or saline placebo
KAVI-Kangemi clinic, Nairobi
Collaborators (1)
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
International AIDS Vaccine Initiative
NETWORK
Karolinska Institutet
OTHER
University of Nairobi
OTHER
Ichor Medical Systems Incorporated
INDUSTRY
University of Oxford
OTHER